SSSamuel Streicher

Samuel Streicher

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samuel Streicher has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Psychedelics as moral bioenhancers: Protocol for a scoping review of ethical arguments for and against

    by Samuel Streicher, Christopher Register, Xiu Lim, Maide Barış, Sebastian Porsdam Mann, Katherine Cheung, Emma C Gordon, David Yaden, Julian Savulescu, Brian D. Earp

    Background Moral bioenhancement typically refers to the deliberate use of drugs or biotechnologies, potentially alongside other practices, to attempt to improve oneself morally. In addition to general concerns regarding moral self-bioenhancement, the possibility of using psychedelic substances for such purposes raises distinct ethical questions. As a first step in analysing these questions, we intend to perform a scoping review of the existing arguments for and against the use of psychedelics as moral bioenhancers. We will focus primarily on voluntary use by individuals, although voluntary use by couples or small groups will be considered. The present contribution is a protocol for this scoping review. Methods Our scoping review will adhere to the Joanna Briggs Institute methodology, which involves five stages: (1) identifying the research question, (2) developing the search strategy, (3) setting inclusion criteria, (4) extracting data, and (5) presenting and analysing the results. We will include both published and unpublished sources if they explicitly present ethical arguments for or against the voluntary use of psychedelics as intentional moral bioenhancers in adults. We will search for relevant studies in Embase, MEDLINE, Web of Science, Google Scholar, The National Library of Medicine, the Cumulated Index to Nursing and Allied Health Literature, Philosopher’s Index, the Bioethics Literature Database, EthxWeb, PhilPapers, Stanford Encyclopedia of Philosophy, Philosopher’s Index, EBSCO, BASE, and WorldCat. Sources will be excluded if (a) the full text is inaccessible, (b) the main text is in a language other than English, or (c) the focus is not primarily on ethical arguments (for example, focusing primarily on the clinical use of psychedelics for treatment). Two raters will independently assess all articles for eligibility, with disagreements to be resolved with a third reviewer. Data from eligible articles will be charted using a standardised data extraction form. The data will be analysed following PRISMA-ScR guidelines.


  • Open Access

    The Arabidopsis U1 snRNP regulates mRNA 3’-end processing

    by Anchilie F. Mangilet, Joachim Weber, Sandra Schüler, Irina Droste-Borel, Samuel Streicher, Thomas Schmutzer, Gregor Rot, Boris Macek, Sascha Laubinger

    The removal of introns by the spliceosome is a key gene regulatory mechanism in eukaryotes, with the U1 snRNP subunit of the spliceosome playing a crucial role in the early stages of splicing. Studies in metazoans show that the U1 snRNP also conducts splicing-independent functions, but the lack of genetic tools and knowledge about U1 snRNP-associated proteins have limited the study of such splicing-independent functions in plants. Here, we describe an RNA-centric approach that identified more than 200 proteins associated with the Arabidopsis U1 snRNP, among them mRNA cleavage and polyadenylation factors. The loss of U1 core components is linked to premature cleavage and polyadenylation within gene bodies and alternative polyadenylation site selection in 3’-UTRs. Overall, our work provides a comprehensive view of U1 snRNP interactors and reveals novel functions in regulating mRNA 3’-end processing in Arabidopsis, thus establishing the groundwork for a better understanding of non-canonical functions of plant U1 snRNPs.